首页> Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis> Characterisation of exposure versus response of edoxaban in patients undergoing total hip replacement surgery

Characterisation of exposure versus response of edoxaban in patients undergoing total hip replacement surgery

导出原文传递

翻译打印收藏纠错

第一作者： Rohatagi,S.

作者： Rohatagi,S. ^[1] ; Mendell,J. ^[2] ; Kastrissios,H. ^[3] ; Green,M. ; Shi,M. ; Patel,I. ; Salazar,D.E.

作者单位： Pharsight Corporation, Mountain View, CA, United States ^[1] Daiichi Sankyo Pharma Development, 399 Thornall Street, Edison, NJ 08837, United States ^[2] Daiichi Sankyo India Pharma Private Ltd, Mumbai, India ^[3]

关键词 Edoxaban Factor Xa inhibitor Population pharmacokinetics Venous thromboembolism

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Thrombosis and Haemostasis

2012年108卷5期

887-895页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览3

点击下载本期目录封面

Thrombosis and Haemostasis

2012年108卷5期

887-895页

检索历史清除

Characterisation of exposure versus response of edoxaban in patients undergoing total hip replacement surgery

Thrombosis and Haemostasis

相似文献

同项目论文

Thrombosis and Haemostasis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Characterisation of exposure versus response of edoxaban in patients undergoing total hip replacement surgery

Thrombosis and Haemostasis

相似文献

同项目论文

Thrombosis and Haemostasis

相关期刊

检索历史清除